Straits Research Highlights the Dynamic Growth, Trends, and Opportunities Driving the Market
The global pet cancer therapeutics market is witnessing robust growth, as highlighted in Straits Research’s latest comprehensive report. The market, valued at USD 395.74 million in 2022, is projected to expand significantly to USD 837.75 million by 2031, registering a remarkable compound annual growth rate (CAGR) of 8.69% over the forecast period (2023–2031).
Market Definition
The pet cancer therapeutics market refers to the segment of veterinary healthcare that develops and provides therapies aimed at treating various cancers in animals, particularly pets such as dogs and cats. These therapies include chemotherapy, radiation therapy, immunotherapy, and targeted therapy to address a range of cancers, including lymphoma, melanoma, and mast cell cancer, among others. With the rising prevalence of cancer in pets and increased awareness among pet owners, the demand for effective cancer treatment solutions is escalating.
Get a Full PDF Sample Copy of the Report
Latest Market Trends
Rise of Immunotherapy in Veterinary Medicine: Immunotherapy, a revolutionary approach in human oncology, is gaining traction in veterinary medicine. This treatment modality enhances the immune system’s ability to target and destroy cancer cells, offering improved outcomes for pets.
Advancements in Diagnostic Technologies: Cutting-edge diagnostic tools, such as liquid biopsy and next-generation sequencing (NGS), are enabling early cancer detection in pets. These advancements pave the way for timely and precise treatment interventions.
Increased Adoption of Personalized Medicine: Customized therapeutic approaches, tailored to an individual pet’s specific needs and genetic makeup, are becoming more prevalent. This trend underscores a shift toward precision veterinary oncology.
Market Dynamics
Growth Factors
Rising Pet Ownership and Expenditure: The growing pet population worldwide, coupled with increased spending on pet healthcare, is a major driver of the pet cancer therapeutics market.
Advancements in Veterinary Oncology: Ongoing research and development in cancer therapies, including novel drug formulations and combination therapies, are accelerating the availability of effective treatment options.
Growing Awareness Among Pet Owners: Awareness campaigns and educational initiatives about cancer in pets have heightened pet owners’ vigilance, driving demand for early diagnosis and treatment.
Key Market Opportunities
Emerging Markets: Regions such as Asia-Pacific and Latin America present untapped opportunities due to the rising adoption of pets and improving access to veterinary care.
Development of Biologic Therapies: The rise of biologic drugs offers new avenues for treating aggressive and refractory cancers in pets, creating substantial growth potential.
Collaborations and Partnerships: Strategic collaborations between pharmaceutical companies and veterinary research institutions are fostering innovation and market expansion.
Market Segmentation
Key Companies:
AB Science
Boehringer Ingelheim GmbH (Merial)
Vivesto AB (AdvaVet Inc.)
Elanco
ELIAS Animal Health
Karyopharm Therapeutics Inc.
Torigen Pharmaceuticals Inc.
Dechra Pharmaceuticals PLC (Anivive Lifesciences)
Elekta
Virbac
Zoetis
By Therapy:
Chemotherapy
Radiation Therapy
Immunotherapy
Targeted Therapy
Other Therapies
By Animal:
Dog
Cat
Other Animals
By Applications:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Other Applications
Regional Insights
Dominated Region: North America leads the pet cancer therapeutics market, driven by advanced veterinary healthcare infrastructure, high pet adoption rates, and significant R&D investments.
Fastest Growing Region: Europe is emerging as the fastest-growing region due to the rising adoption of innovative veterinary cancer treatments and increased pet healthcare spending.
For More Information or Query or Customization Before Buying, Visit
About Straits Research
Straits Research is a leading market research and consulting firm providing actionable insights and strategic recommendations across various industries. With a focus on delivering high-quality research reports, Straits Research helps businesses navigate market complexities and achieve sustainable growth.
